Clinical Trials Database
This Month's CME & CME News Updates

 

 medworkslogo.gif
we know psychiatry.

Copyright © 2012,
MedWorks Media Global
, Los Angeles, CA.
All rights reserved.

Volume 45, Numbers 1,2012

 

 

 

 

 

 

 

 

 

  

IN PRESS & RECENTLY PUBLISHED: 

  • Zonisamide for Bipolar Depression: a Randomized, Double Blind, Placebo-Controlled, Adjunctive Trial. http://t.co/cn16Yats
    Efficacy and Safety of Paliperidone Extended Release 1.5 mg/day..A Double-blind, Patients with Schizophrenia. http://t.co/cn16Yats
    Ramelteon for Insomnia Related to Attention-Deficit/ Hyperactivity Disorder. http://t.co/cn16Yats
    Extended Release Quetiapine Fumarate (quetiapine XR) as Adjunct Therapy in Patients with GAD…Double-Blind. http://t.co/cn16Yats

 Previous Issues:

 Original Research



 

 


While all readers are welcome to explore brainscience.com, this site is designed for mental healthrofessionals with a keen interest in the brain sciences. Many articles are technical, and originate from peer-review journals. Best of luck and good reading. —The Editors

1274608-665501-thumbnail.jpg
Michael E. Thase, MD, Editor-In-Chief
A Long-Revered Resource in Academia

Published from 1965 until 1999 by the National Institute of Mental Health (NIMH), Psychopharmacology BULLETIN forged its path just as psychiatry itself was embarking on its golden era of treatment breakthroughs and recognition as a valid and independent field of medicine. Within months of MedWorks Media acquiring the rights to the title, the beloved Psychopharmacology BULLETIN was given a facelift, and a powerhouse Editor


The ABCs of Trends: A Mission of Influence

[ndexed in a variety of databases including Index Medicus and PubMed since 1966, Bulletin’s influential name carries with it a certain responsibility to make sense of the trends in medicine for clinicians. With the primary catalyst for cutting-edge remission treatment in anxiety and depression—Michael E. Thase, MD—on board as the new Editor, the Bulletin will cover evidence-based medicine as a section in every issue, along with original works on drug interactions and neuroscientific updates in translational work and imaging. Dr. Thase’s focus is on the future, on broadening the Bulletin’s scope, fostering an ability to engage readers actively, and expanding its already formidable sphere of influence in the field of neuropsychiatry. editorial board masthead

 

Saturday
Nov102007

Enduring Materials in Both English and Spanish

1274608-899882-thumbnail.jpg1274608-899894-thumbnail.jpg

          Contact Information for Special Projects

 

                                    1274608-899880-thumbnail.jpg1274608-899889-thumbnail.jpg1274608-899883-thumbnail.jpg

1274608-899879-thumbnail.jpg